安保工程控股(01627.HK)擬1.81億港元收購佳祺全部股權
格隆匯2月20日丨安保工程控股(01627.HK)發佈公吿,2022年2月18日,公司間接全資附屬公司Tregunter Global(作為買方)與魏振雄先生(作為賣方)訂立該協議,據此,Tregunter Global有條件同意收購佳祺的待售股份及待售貸款,代價為1.814億港元。
佳祺於2016年成立,為於香港註冊成立的投資控股公司,由魏先生直接持有。榮康順新能源的主要業務為持有博羅縣龍溪鎮埔上村委會紅星村、東風村東邊溢(土名)的土地使用權,現正在該土地上建造工廠、辦公室及相關處所。榮康順新能源的全部股權由佳祺持有。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.